CapsoCam Plus® has been proven to be a safe and effective diagnostic tool. Ongoing research and clinical evaluations continue to expand the range of clinical indications.
Clinical outcomes from international studies performed with the CapsoCam small bowel capsule. These studies have not been evaluated by the U.S. Food and Drug Administration (FDA).
Thomas Pachofszky M.D. -Dept. of Gastroenterology, Hepatology and Endoscopy Hospital, Rudolfstiftung, Vienna, Austria Presented at UEGW 2019, Barcelona, Spain